Ęterna Zentaris Financial Statements
Ęterna Zentaris Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Ęterna Zentaris Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 42.1 | 41.4 | 247.4 |
| Gross Profit ($ mil.) | 29.1 | 29.6 | 91.0 |
| Operating Income ($ mil.) | (33.2) | (21.8) | 20.5 |
| Total Net Income ($ mil.) | (37.4) | 34.3 | 16.0 |
| Diluted EPS (Net Income) | (0.70) | 0.64 | 0.22 |
Ęterna Zentaris Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 1.72 | 3.77 | 1.54 |
| Price/Earnings Ratio | -- | 15.99 | 15.14 |
| Price/Book Ratio | 0.97 | 2.70 | 1.46 |
| Price/Cash Flow Ratio | -- | 11.60 | 9.41 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Ęterna Zentaris Financial Ratios
Ęterna Zentaris Competitive Intelligence
| Celgene | EntreMed | ImClone | |
|---|---|---|---|
| Annual Sales ($ mil.) | 1,405.8 | 7.4 | 590.8 |
| Employees | 1,685 | -- | 1,128 |
| Market Cap ($ mil.) | 26,259.2 | 47.2 | 3,372.2 |
Competitive Landscape
